GlassScriptPhysician profile
Samantha Cote
NPI 1063086163
$2,625.15
in general payments reported to CMS, 2019-2025
16 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $428 · 2022: $450 · 2023: $789 · 2024: $629 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,520 · Entertainment: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,520.02 |
| Entertainment | $227.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $312.31 | 2021-2025 | Rocklatan, Simbrinza, Rhopressa |
| Coopervision INC. | $291.18 | 2023-2025 | Myday Contact Lens, Misight Contact Lens |
| Sun Pharmaceutical Industries INC. | $244.41 | 2022-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $228.86 | 2021 | |
| Optos, INC. | $227.94 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $213.97 | 2023-2024 | Tyrvaya |
| Sight Sciences, INC. | $153.64 | 2022 | |
| Abbvie INC. | $146.75 | 2024 | |
| Mallinckrodt Hospital Products INC. | $121.87 | 2023 | Acthar |
| Genentech USA, INC. | $121.83 | 2022 | |
| Dompe US, INC. | $121.60 | 2024 | Oxervate |
| Horizon Therapeutics Plc | $120.00 | 2023 | Tepezza |
| Amgen INC. | $118.52 | 2025 | Tepezza |
| Biotissue Holdings INC. | $83.30 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $71.62 | 2021-2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $47.35 | 2022-2024 | Infuse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Cote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.